Aspen Pharmacare Holdings Ltd. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Aspen Pharmacare Holdings Ltd.

Aspen Pharmacare Holdings Ltd.

Aspen Pharmacare Holdings Ltd.
Stock Exchange	Other OTC
EPS	$0.87
Market Cap	$3.29 B
Shares Outstanding	456.44 M
Public Float	-

Aspen Pharmacare Holdings Ltd. ADR
Stock Exchange	Other OTC
EPS	$0.87
Market Cap	$3.18 B
Shares Outstanding	456.45 M
Public Float	-

Aspen Pharmacare Holdings Ltd.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	456.44 M
Public Float	-

Aspen Pharmacare Holdings Ltd.
Stock Exchange	Johannesburg Stock Exchange
EPS	ZAC11.5
Market Cap	ZAC45.43 B
Shares Outstanding	456.45 M
Public Float	346 M

Profile

Address	Aspen Place, 9 Rydall Vale Park Durban NL 4019 South Africa
Employees	-
Website	http://www.aspenpharma.com
Updated	07/08/2019
Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products. The firm operates through the following segments: Commercial Pharmaceuticals, Nutritionals, and Manufacturing. The Commercial Pharmaceuticals segment comprises of the Anaesthetic; Thrombosis; High Potency and Cytotoxics; and Other Commercial Pharmaceutical Brands.

Financials

Stephen Bradley Saad

Group Chief Executive Officer & Executive Director

Michael Guy Attridge

Executive Director & Group Deputy CEO